| |
| |
|
| Insider
Information: |
Meredith Ian T |
| Relationship: |
EVP Global Chief Med O... |
| City: |
Marlborough |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
28,082 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,022,746 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,082 |
|
|
| Total
Value |
$2,022,746 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP Global Chief Med O... |
2022-03-28 |
28,082 |
2018-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-03-28 |
4 |
AS |
$43.68 |
$287,764 |
D/D |
(6,588) |
28,082 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$13,251 |
D/D |
(300) |
34,670 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,019 |
34,970 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$12,680 |
D/D |
(298) |
33,951 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,013 |
34,249 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,037 |
33,541 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$12,978 |
D/D |
(305) |
33,236 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-17 |
4 |
D |
$42.83 |
$15,719 |
D/D |
(367) |
32,504 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
32,871 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,108 |
31,947 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-15 |
4 |
D |
$44.01 |
$14,347 |
D/D |
(326) |
31,621 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-01 |
4 |
D |
$43.50 |
$39,977 |
D/D |
(919) |
30,839 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,131 |
31,758 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,649 |
29,892 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2022-01-01 |
4 |
D |
$42.48 |
$53,737 |
D/D |
(1,265) |
28,627 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-12-28 |
4 |
AS |
$43.21 |
$303,248 |
D/D |
(7,018) |
26,243 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-28 |
4 |
D |
$38.78 |
$11,595 |
D/D |
(299) |
32,553 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,018 |
32,852 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,012 |
32,132 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-21 |
4 |
D |
$38.03 |
$11,333 |
D/D |
(298) |
31,834 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-18 |
4 |
D |
$37.52 |
$11,444 |
D/D |
(305) |
31,120 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,037 |
31,425 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-15 |
4 |
D |
$38.39 |
$12,477 |
D/D |
(325) |
30,388 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,107 |
30,713 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP Global Chief Med Officer |
• • – |
2021-02-10 |
4 |
D |
$38.85 |
$49,262 |
D/D |
(1,268) |
29,606 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
